차이나 파마 홀딩스 (CPHI) 주가 전망: 목표주가, 배당, 최신 뉴스

China Pharma Holdings, Inc. develops, manufactures, and markets pharmaceutical products for human use in the People's Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.

Its products include Cerebroprotein Hydroloysate injection to treat memory decline and attention deficit; Gastrodin injection for tiredness, loss of concentration, poor sleep, and traumatic syndromes of the brain; Propylgallate injection to treat cerebral thrombosis, coronary heart disease, and after surgery complications; Ozagrel Sodium to treat acute thrombotic cerebral infarction and dyskinesia; Alginic Sodium Diester injection for ischemic heart, cerebrovascular, and high lipoprotein blood diseases; Bumetanide injection for edema diseases, hypertension, acute renal failure, hyperkalemia, hypercalcemia, and acute drug poisoning; and Candesartan for hypertension.

It offers Roxithromycin dispersible tablets for pharyngitis and tonsillitis; Cefaclor dispersible tablets for tympanitis, lower respiratory tract infection, urinary tract infections, and skin/skin tissue infection; Cefalexin capsules for acute tonsillitis; Andrographolide for sore throat caused by upper respiratory tract infection; Clarithromycin granules and capsules; and Naproxen Sodium and Pseudophedrine Hydrochlorida sustained release tablets, as well as Hepatocyte growth-promoting factors, Tiopronin, Compound Ammonium Glycyrrhetate S, and Omeparzole for the treatment of digestive diseases.

In addition, the company provides Vitamin B6 injection; Granisetron Hydrochloride injection for nausea and vomiting caused by radiotherapy and chemotherapy during the treatment of malignant tumors; Noni Enzyme, a food supplement; sanitizers; and masks. It supplies its products to hospitals and OTC pharmacies through provincial and municipal pharmaceutical logistics companies. The company is based in Haikou, the People's Republic of China.

China Pharma Holdings, Inc.은 중국에서 인체용 의약품을 개발·제조·판매합니다. 제품 형태는 건조 분말 주사제, 액상 주사제, 정제, 캡슐 및 세파계 경구용 용액 등입니다.

주요 제품으로는 Cerebroprotein Hydroloysate injection(기억력 저하·주의력 결핍 치료), Gastrodin injection(피로·집중력 저하·수면 장애·두부 외상 증상), Propylgallate injection(뇌혈전증·관상동맥심장질환·수술 후 합병증), Ozagrel Sodium(급성 혈전성 뇌경색·운동장애), Alginic Sodium Diester injection(허혈성 심장·뇌혈관 질환 및 고지단백혈증), Bumetanide injection(부종·고혈압·급성신부전·고칼륨혈증·고칼슘혈증·급성 약물 중독), Candesartan(고혈압) 등이 있습니다. 또한 Roxithromycin dispersible tablets(인두염·편도선염), Cefaclor dispersible tablets(중이염·하부호흡기 감염·요로감염·피부 조직 감염), Cefalexin capsules(급성 편도염), Andrographolide(상기도 감염으로 인한 인후통), Clarithromycin granules and capsules, Naproxen Sodium 및 Pseudophedrine Hydrochlorida sustained release tablets 등 항생제·진통제 계열과 Hepatocyte growth-promoting factors, Tiopronin, Compound Ammonium Glycyrrhetate S, Omeparzole 등 소화기계 치료제를 보유하고 있습니다.

이 밖에 Vitamin B6 injection, Granisetron Hydrochloride injection(항암·방사선화학요법으로 인한 구역·구토), Noni Enzyme(건강기능식품), 살균제 및 마스크 등을 제공합니다. 제품은 성·시 의약 물류 회사를 통해 병원 및 OTC 약국에 유통되며, 본사는 중국 하이커우에 위치해 있습니다.

• 주소: No. 17, Jinpan Road, Second Floor, Haikou, 570216, China

• 전화번호: 86 89 8668 11730

• 웹사이트: https://www.chinapharmaholdings.com

• 섹터: Healthcare

• 산업: Drug Manufacturers - Specialty & Generic

• 직원 수: 215